[Federal Register Volume 71, Number 143 (Wednesday, July 26, 2006)]
[Notices]
[Pages 42556-42561]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 06-6492]



[[Page 42555]]

-----------------------------------------------------------------------

Part IV





Department of Education





-----------------------------------------------------------------------



Grants and Cooperative Agreements--Notice of Final Priority and Notice 
Inviting Applications for New Awards; Notices

  Federal Register / Vol. 71, No. 143 / Wednesday, July 26, 2006 / 
Notices  

[[Page 42556]]


-----------------------------------------------------------------------

DEPARTMENT OF EDUCATION

RIN 1865-ZA03


Grants for School-Based Student Drug-Testing Programs

AGENCY: Office of Safe and Drug-Free Schools, Department of Education 
(ED).

ACTION: Notice of final priority, eligibility and application 
requirements, and selection criteria.

-----------------------------------------------------------------------

SUMMARY: The Assistant Deputy Secretary for Safe and Drug-Free Schools 
announces a priority, eligibility and application requirements, and 
selection criteria under the School-Based Student Drug-Testing Programs 
grant program. The Assistant Deputy Secretary may use this priority, 
eligibility and application requirements, and selection criteria for 
competitions in fiscal year (FY) 2006 and later years. We intend for 
the priority, eligibility and application requirements, and selection 
criteria to support development and implementation of drug-testing 
programs in schools.

DATES: Effective Date: This priority, eligibility and application 
requirements, and selection criteria are effective August 25, 2006.

FOR FURTHER INFORMATION CONTACT: Robyn L. Disselkoen, or Charlotte 
Gillespie, U.S. Department of Education, 400 Maryland Avenue, SW., room 
3E328, Washington, DC 20202-6450.
    If you use a telecommunications device for the deaf (TDD), you may 
call the Federal Relay Service (FRS) at 1-800-877-8339.
    Individuals with disabilities may obtain this document in an 
alternative format (e.g., Braille, large print, audiotape, or computer 
diskette) on request to the contact person listed under FOR FURTHER 
INFORMATION CONTACT.

SUPPLEMENTARY INFORMATION: We published a notice of proposed priority, 
eligibility and application requirements, and selection criteria for 
this program (NPP) in the Federal Register on May 22, 2006 (71 FR 
29321). We discussed our proposals for this program in the NPP (71 FR 
29322-29324).
    This notice of final priority, eligibility and application 
requirements, and selection criteria (NFP) contains three changes from 
the NPP. We fully explain these changes in the Analysis of Comments and 
Changes section that follows.

Analysis of Comments and Changes

    In response to our invitation in the NPP, five parties submitted 
comments. An analysis of the comments and of any changes in the 
priority, eligibility and application requirements, and selection 
criteria follows. We group major issues according to subject. 
Generally, we do not address technical and other minor changes and 
suggested changes the law does not authorize us to make under the 
applicable statutory authority.

Eligible Applicants

    Comment: One commenter argues that isolated rural local educational 
agencies (LEAs) should be allowed to participate in the program with 
one high school and one middle school rather than with two high 
schools.
    Discussion: While school districts with only one high school have 
been eligible for a grant under previous competitions for this program, 
we are restricting the group of eligible applicants to districts with 
at least two high schools for purposes of the national evaluation of 
this program that ED will be conducting. The evaluation design will 
randomly assign schools either to the treatment condition (implementing 
the drug testing program) or to the control condition (delaying 
implementation of the drug testing program for approximately one year). 
The prevalence of drug use among students in the treatment school will 
be compared against drug use in the control school. The commenter's 
proposal to allow a high school and a middle school to be randomly 
assigned would violate key principles of the random assignment design, 
because ED believes that the impact of a mandatory random drug-testing 
program is likely to be quite different in a high school setting versus 
a middle school setting. Comparing student drug use between schools at 
different levels, therefore, would not be desirable.
    Change: None.

Scope of Program

    Comment: One commenter believes that drug testing is ineffective at 
deterring drug abuse and is harmful for students. The commenter 
suggests that funding should be concentrated on promoting accurate, 
fact-based education and discussion of the dangers of drug use, as well 
as increased involvement in extra-curricular activities.
    Discussion: The purpose of the evaluation is to build a more robust 
body of evidence on mandatory random student drug testing (MRSDT) using 
a randomized control design, the ``gold standard'' method for 
determining whether an intervention is effective. ED will use this 
rigorous design to determine if drug testing is effective among the 
group of districts that receive grants under this competition. We 
recognize that drug testing is a tool that must be used in conjunction 
with a comprehensive drug and alcohol prevention program. For this 
reason, ED requires that applicants describe the prevention program 
they currently have in place and explain how drug testing will be a 
part of that program. We also agree that strategies to promote 
participation in extra-curricular activities are important. Such 
participation helps to create a bond between the student and the school 
that can improve academic performance as well as deter high-risk 
behaviors, including drug and alcohol use. This study will gather 
information on the impact of MRSDT on rates of participation in extra-
curricular activities.
    Change: None.
    Comment: One commenter stated that the evaluation would be based on 
too small a sample to be meaningful because grantees are also subject 
to the laws in their respective States and case law on mandatory random 
drug testing in many States is not yet settled.
    Discussion: We agree with the commenter that this area of the law 
is evolving, and that is why we have included Eligibility and 
Application Requirement 2(f)(iv), which requires applicants to provide 
a written assurance ``that legal counsel has reviewed the proposed 
drug-testing program and advised that the program activities do not 
appear to violate established constitutional principles or State and 
Federal requirements related to implementing a mandatory random student 
drug-testing program.'' We do not agree, however, that the sample size 
will be too small to be meaningful. The primary purpose of the 
evaluation is to determine whether there is a significant impact of 
mandatory random drug testing among the ED grantees selected under this 
competition. The evaluation is not intended to be nationally 
representative nor statistically generalizable beyond this group of 
grantees. We expect that the grantees will have a sufficient number of 
participating schools to provide meaningful study results. We have 
designed the study to detect a 10.2 percent reduction in the 30-day 
prevalence of illicit drug use. In order to detect this effect, we need 
30 schools. Our assumptions for the study design are: (1) A two-tailed 
test at 80 percent power and a 5 percent statistical significance; (2) 
an R\2\ value of 0.05 because of the use of prior student drug use as a 
covariate; (3) a non-random sample of 30 schools with random assignment 
of 15 schools to receive the

[[Page 42557]]

intervention and 15 schools to serve as controls; (4) a minimum sample 
size of 200 students per school with an 80 percent response rate; and 
(5) an intra-class correlation coefficient of 0.05. We estimate that 
this design would generate minimum detectable effects (MDE) of 
approximately 0.17 standard deviation for continuous outcomes and 7.8 
percent for binary outcomes where the control group mean is 30 percent. 
Because the sample of schools is purposive, and statistically 
generalizing beyond this sample is not valid, we have calculated the 
power with a fixed effects, rather than a random effects, framework. 
Under our assumptions, a sample of 30 schools would be sufficient to 
detect the reduction of 10.2 percent in the 30-day prevalence of use of 
any illicit drug. If the true impact were smaller than the MDE, that 
would not challenge the validity of the study, only its precision in 
detecting smaller impacts from drug-testing programs.
    Change: None.
    Comment: One commenter believes the control condition should 
include alternatives to drug testing, such as screening all students 
for drug use and severity via a brief professional interview, rather 
than simply ``no intervention.''
    Discussion: The commenter raises important drug testing program 
design issues regarding the control condition and suggests that other 
substance abuse prevention strategies be tested. That is beyond the 
scope of this evaluation, given that the central policy question of 
interest addressed by this evaluation is whether MRSDT has an impact on 
student drug use. Once that hypothesis has been tested, ED may decide 
to research alternative prevention strategies to determine whether they 
are more or less effective than MRSDT.
    Change: None.
    Comment: One commenter believes that the evaluation should monitor 
unintended consequences (such as successful evasion of the test, 
falsification of results, false negatives, and false positives) in 
addition to looking at the efficacy of drug testing.
    Discussion: We agree that careful consideration of unintended 
impacts of MRSDT programs on high school students is important. To that 
end, the student survey will gather information on the impact of drug 
testing on students' participation in athletics and extra-curricular 
activities. Addressing the specific concerns raised by the commenter, 
however, is beyond the scope of the current evaluation.
    The study is designed to assess the impact of MRSDT on reported 
substance use by students subject to and not subject to MRSDT in their 
schools, while ensuring the confidentiality of all students subject to 
drug testing in schools that implement the policy. In order for the 
national evaluator to measure successful evasion of the test or 
falsification of results, the test results would have to be linked to a 
specific student's questionnaire. This study has been carefully 
designed to avoid that linkage and to protect the privacy of student 
participants.
    Change: None.

Institutional Review Board (IRB) Approval

    Comment: One commenter objected to ED's interpretation of the IES 
(Institute of Education Sciences) confidentiality statutes as exempting 
grantees from the need to have separate IRB approvals and noted that 
the proposal did not make clear how or why the research would pass 
muster under the IES ethical guidelines.
    Discussion: While research conducted under the strict 
confidentiality requirements of the IES confidentiality statute is not 
subject to IRB review, as a policy matter, ED will obtain IRB approval 
for all human subjects research activities, in accordance with the 
Common Rule for the protection of human subjects in research (34 CFR 
part 97). The exemption for research done under the IES Confidentiality 
statute from the Common Rule for the protection of human subjects is 
based on the fact that the Confidentiality statute prohibits the 
disclosure of any information that could lead to the identification of 
an individual participating in the survey. This is a significantly 
higher standard than the protection of privacy under such acts as the 
Privacy Act of 1974, which only prohibits the disclosure of 
individually identifiable information. Not only does the 
Confidentiality statute prohibit disclosure of information that could 
potentially lead to the identification of an individual, it contains 
criminal penalties for disclosure. The statute also provides that 
information collected under the Confidentiality statute is immune from 
legal process. See 20 U.S.C. 9007. Even though there is the highest 
degree of protection for data collected under the Confidentiality 
statute, the Department is very interested in protecting study 
participants from harm. That is why we have decided to subject the 
research design, including review of the informed consent forms, to 
review by an IRB.
    The national evaluator will obtain both parental consent and 
student assent for student participation in the surveys, conduct all 
data collection for the research, analyze the data, and ensure strict 
confidentiality under the highest standards required by the IES 
Confidentiality statute. The grantees will provide the research sites, 
however, they will not be conducting research because all research 
activities will be conducted by the national evaluator that has a 
contract with ED to do the research. If the grantees decided to engage 
in human subjects research, for example, as part of separate project 
evaluations, they would need IRB approval for their separate research. 
The IES statutes require that IES contractors maintain strict data 
confidentiality standards. There will be compliance with these 
statutory requirements and ethical guidelines.
    Change: None.

Testing Pool

    Comment: One commenter stated that it should be made clear in 
student informed consent forms, or otherwise, whether participation in 
the evaluation is or is not a condition for participation in athletic 
programs or competitive extra-curricular activities, and whether 
students may ``opt out'' of the research.
    Discussion: Participation in student surveys to be conducted by the 
evaluator is completely voluntary and is not a condition of 
participation in athletics or extra-curricular activities. If a parent 
or a student who is 18 years of age or older or who is an emancipated 
minor under State law does not sign an evaluation consent form to 
participate in the evaluation's student surveys, this will have no 
effect on that student's eligibility to participate in the school's 
athletic program or competitive extra-curricular activities. In fact, 
because participation by the student in the research requires the 
student's assent, even if the student refuses to complete the survey 
when a parent has consented, the student will remain fully eligible to 
participate in the school's athletic program or competitive extra-
curricular activities. We will add information to the application 
package to make clear the voluntary, non-coercive nature of 
participation in the student surveys and we will direct the national 
evaluator to add this information to consent forms. The IRB will review 
the consent forms used in the evaluation research for compliance with 
the regulations for the protection of human subjects (34 CFR part 97). 
This review will include assessment of the adequacy of the consent 
form's information about the voluntary nature of participation in 
research.
    Change: None.

[[Page 42558]]

    Comment: One commenter argued that the LEA is considered 
``temporary staff'' under the IES statute and should not view or 
evaluate any test results. The commenter believes that allowing the LEA 
to collect test results creates the potential for mishandling sensitive 
student information. Instead, the commenter suggests that the test 
results be transmitted directly to the national evaluator without 
personally identifiable student information.
    Discussion: We do not agree that the LEA should be considered 
``temporary staff'' because it will have no part in conducting the 
evaluation. We also do not agree that the LEA should not view or 
evaluate test results. Information about positive drug test results is 
a necessary part of the school's operation of a drug-testing program. 
Without that information, the LEA would not be able to initiate 
appropriate intervention such as referral to a student assistance 
program, counseling, or drug treatment. Student drug test results are 
protected as education records under the Family Educational Rights and 
Privacy Act (FERPA) because the information is directly related to a 
student and maintained by the LEA or a party acting for the LEA. (20 
U.S.C. 1232g(a)(4)(A)). Additionally, in order to further protect 
against mishandling of sensitive student information, applicants must, 
as a condition of receiving a grant award, agree to a stringent set of 
pupil privacy protections, including limiting the number of persons 
with access to the test results, destroying test results when the 
student graduates or otherwise leaves the LEA, and carrying out all 
proposed activities in accordance with both FERPA and Protection of 
Pupil Rights Amendment. (20 U.S.C. 1232h). In addition, the data 
regarding test results will be transmitted to the national evaluator 
without personally identifiable student information. Thus, there will 
be no way the evaluator can identify students who tested positive or 
connect the survey results with the drug-testing results.
    Change: None.
    Comment: One commenter expressed the view that the program's 
requirements should only subject students to mandatory random drug 
testing while they are participating in the school's athletic program 
or in competitive extra-curricular activities.
    Discussion: We agree that this requirement needs to be clarified. 
We intend to give applicants flexibility to propose drug-testing 
programs that take into consideration the special needs and 
circumstances in the LEA; are consistent with their adopted policies; 
and are in accordance with the decisions of the U.S. Supreme Court in 
Vernonia School District 47J v. Acton, 515 U.S. 646 (1995), and Board 
of Education of Independent School District No. 92 of Pottawatomie 
County v. Earls, 536 U.S. 822 (2002) and advice of the LEA's legal 
counsel. Therefore, we will not require that students remain in the 
testing pool when they are not participating in a covered activity, but 
leave the length of time students are subject to testing to the 
discretion and policies of each district.
    Change: We have changed the eligibility and application requirement 
in paragraph (2)(f)(viii) to read: ``That schools randomly assigned to 
begin drug testing in year one of the grant will not be required to 
consider students to be in the testing pool at any specific point in 
time unless they are participating in a covered activity (for example, 
all students participating at that time in athletics and/or all 
students participating at that time in competitive, extra-curricular, 
school-sponsored activities).''

Drug-Test Results

    Comment: One commenter stated that the requirement for all positive 
drug tests to be reviewed by a certified medical review officer is too 
vague. The commenter suggested that grantees use urine tests 
administered in compliance with the Mandatory Guidelines for Federal 
Workplace Drug Testing Programs, which require that all positive urine 
tests be confirmed by a gas chromatography/mass spectrometry-certified 
lab.
    Discussion: Although the majority of current grantees use urine 
tests, a few have opted to use saliva or hair tests. We do not intend 
to require grantees to use any specific test but, rather, leave it to 
local discretion, determined in consultation with local counsel, and 
taking into consideration the U.S. Supreme Court decisions in Vernonia 
School District 47J v. Acton, 515 U.S. 646 (1995), and Board of 
Education of Independent School District No. 92 of Pottawatomie County 
v. Earls, 536 U.S. 822 (2002) and the special needs and circumstances 
in the LEA. We agree, however, that all positive tests, whether by 
urinalysis or other method, should be subject to confirmation by a 
method appropriate for the type of test administered. For a positive 
urine test, gas chromatography/mass spectrometry is the preferred 
method for confirming test results. We also agree that further 
clarification is needed regarding the requirement that positive test 
results be reviewed by a certified medical review officer (MRO).
    Change: We have modified the eligibility and application 
requirement in paragraph 2(f)(iii) to read: ``That all positive drug 
tests will be subject to confirmation by a method appropriate for the 
type of test administered and that positive results will be reviewed 
and verified by a certified medical review officer, a licensed 
physician who is also an expert in drug and alcohol testing and the 
Federal regulations governing such testing.''
    Comment: One commenter suggests that the five-panel test 
(marijuana, amphetamine, cocaine, methamphetamine, and opiates) is too 
broad and runs the risk of creating false positives for students using 
prescription medicine. The commenter believes the categories of drugs 
tested should be limited.
    Discussion: The five-panel test is a standard test that screens for 
the presence of five substances commonly used by young people. We think 
it is important that schools test for, at a minimum, these commonly 
used substances in order to identify students who have initiated drug 
use and ensure they receive the help they need. Limiting the number of 
drugs for which schools may test runs the risk of failing to identify 
some students. The five-panel test provides an appropriate balance 
between testing for too few drugs and too many drugs. The requirement 
for referral to an MRO is intended to guard against reporting a 
positive drug test when the student is using a medicine legally 
prescribed for him or her.
    Change: None.

SAMHSA-Certified Labs

    Comments: None.
    Discussion: Upon our further review of the proposed selection 
criteria, we believe that paragraph (a) under the Management Plan 
criterion should be changed. Under this criterion as proposed, 
applicants would have been required to demonstrate a commitment to 
using SAMHSA-certified labs to process student drug tests. ED has since 
learned that many of these labs are not geographically accessible to 
all grantees. In order to give grantees the option to select any 
qualified lab, we are changing this selection criterion to permit 
applicants to use any federally or nationally accredited lab.
    Change: We have changed paragraph (a) of the Management Plan 
selection criterion to read: ``The extent to which the applicant 
describes appropriate chain-of-custody procedures for test samples and 
demonstrates a commitment to using a federally or

[[Page 42559]]

nationally accredited lab to process student drug tests.''

    Note: This notice does not solicit applications. In any year in 
which we choose to use the priority, eligibility and application 
requirements, and selection criteria, we invite applications through 
a notice in the Federal Register. When inviting applications, we 
designate each priority as absolute, competitive preference, or 
invitational. The effect of each priority is as follows:
    Absolute priority: Under an absolute priority we consider only 
applications that meet the priority (34 CFR 75.105(c)(3)).
    Competitive preference priority: Under a competitive preference 
priority we give competitive preference to an application by either 
(1) awarding additional points, depending on how well or the extent 
to which the application meets the competitive priority (34 CFR 
75.105(c)(2)(i)); or (2) selecting an application that meets the 
competitive priority over an application of comparable merit that 
does not meet the priority (34 CFR 75.105(c)(2)(ii)).
    Invitational priority: Under an invitational priority we are 
particularly interested in applications that meet the invitational 
priority. However, we do not give an application that meets the 
invitational priority a competitive or absolute preference over 
other applications (34 CFR 75.105(c)(1)).

Priority

Participation in Evaluation of Mandatory Random Student Drug-Testing 
Programs
    Under this priority, we will support local educational agencies 
(LEAs) that agree to participate in a national evaluation of the impact 
of mandatory random student drug testing on high school students' 
reported substance use. In order to meet this priority, an applicant 
must:
    (1) Agree to carry out its drug-testing program in a manner 
consistent with the randomized control trial evaluation design 
developed by ED and its national evaluator;
    (2) Propose at least two schools with three or more grades 9 
through 12 to participate in the national evaluation;
    (3) Not have an existing drug-testing program in operation in any 
of the schools proposed by the applicant for participation in the 
national evaluation;
    (4) Consent to the evaluator's random assignment of one-half of the 
schools proposed by the applicant for participation in the national 
evaluation to begin mandatory random student drug-testing 
implementation in year one of the grant (following the spring 2007 
survey of students), and one-half to begin mandatory random student 
drug testing approximately one year later (after the spring 2008 survey 
of students has been completed);
    (5) Agree that the schools proposed by the applicant for 
participation in the national evaluation will limit their mandatory 
random student drug-testing program to students in grades 9 through 12 
and, within that group of students, to one or both of the following:
    (a) All students who participate in the school's athletic program; 
and
    (b) All students who are engaged in competitive, extra-curricular, 
school-sponsored activities;

    Note: Competitive, extra-curricular, school-sponsored activities 
mean any activity under the direct control of the school in which 
students compete against students in another school. If the State 
maintains a list of sanctioned, competitive, extra-curricular, 
school-sponsored activities, the applicant may consider those 
activities to be competitive, extra-curricular, school-sponsored 
activities for the purposes of this program.

    (6) Not promote or begin the implementation of its mandatory random 
student drug-testing program in any participating schools until it 
receives notification from the national evaluator about the random 
assignment of its schools to participate in the first or second wave of 
implementation, except that an applicant may conduct outreach and 
generate community support for its drug-testing policy;
    (7) Delay the promotion, announcement, and start of the mandatory 
random student drug-testing program in schools assigned to the second 
wave of implementation until the spring 2008 student survey has been 
completed;
    (8) Implement its mandatory random student drug-testing program 
consistently across participating schools and according to uniform LEA 
policies and procedures during the evaluation period; and
    (9) Provide contact information to the national evaluator in order 
for the evaluator to obtain (a) the prior written consent of either the 
parent or the student if the student is 18 years of age or older or is 
an emancipated minor under State law and (b) student assent for student 
participation in the surveys (if the student does not have the right to 
consent as stated in this paragraph) and make available space for the 
administration of the surveys in the schools.
    Once a participating school has begun implementing its mandatory 
random student drug-testing program in accordance with the requirements 
of this priority, and following the completion of the spring 2008 
student survey, the LEA, at its discretion, may announce, promote, 
implement, and use grant funds for testing--
    (a) In schools assigned to the second wave of implementation;
    (b) Students in any grade 6 through 12 who, along with their parent 
or guardian, volunteer to be tested; and
    (c) Students in grades 6 through 8 who participate in the school's 
athletic programs or competitive, extra-curricular, school-sponsored 
activities.
    Eligibility and Application Requirements: We establish the 
following eligibility requirements for applications submitted under 
this program:
    (1) LEAs are the only eligible applicants; and
    (2) An applicant may not have been the recipient of, or a 
participant in, a grant in 2005 under ED's School-Based Grants for 
Student Drug-Testing competition (84.184D).
    The following requirements also apply to all applications submitted 
under this program:
    (1) An applicant may not submit more than one application for a 
grant under the competition.
    (2) In its application, an applicant must:
    (a) Clearly identify the student population that will be in the 
drug-testing pool including, to the extent feasible, the number of 
students in the pool by grade, and demonstrate a significant need for 
drug testing within the target population;
    (b) Propose to test a minimum of 50 percent of the testing pool 
annually, and use at least a five-panel test (marijuana, amphetamine, 
cocaine, methamphetamine, and opiates);
    (c) Explain how the proposed drug-testing program will be part of 
an existing, comprehensive drug prevention program in the schools to be 
served;
    (d) Provide a comprehensive plan for referring students who are 
identified through the testing program as users of illegal drugs or 
legal medications taken without a prescription to a student assistance 
program, counseling, or drug treatment if necessary;
    (e) Provide a plan to ensure the confidentiality of drug-testing 
results, including a provision that prohibits the party conducting drug 
tests from disclosing to school officials any information about a 
student's use of legal medications for which the student has a 
prescription;
    (f) Provide written assurances of the following:
    (i) That results of student drug tests will not be disclosed to law 
enforcement officials;
    (ii) That results of student drug tests will be destroyed when the 
student graduates or otherwise leaves the LEA or private school 
involved;
    (iii) That all positive drug tests will be subject to confirmation 
by a method

[[Page 42560]]

appropriate for the type of test administered and that positive results 
will be reviewed and verified by a certified medical review officer, a 
licensed physician who is also an expert in drug and alcohol testing 
and the Federal regulations governing such testing;
    (iv) That legal counsel has reviewed the proposed drug-testing 
program and advised that the program activities do not appear to 
violate established constitutional principles or State and Federal 
requirements related to implementing a mandatory random student drug-
testing program;
    (v) That all proposed activities will be carried out in accordance 
with the requirements of the Family Educational Rights and Privacy Act 
(FERPA) and the Protection of Pupil Rights Amendment (PPRA);
    (vi) That the mandatory random student drug-testing program is 
ready to begin no later than 9 months after receipt of the grant award. 
We will consider a grantee's failure to achieve readiness to begin its 
program within 9 months of the grant award as failure to make 
substantial progress consistent with the requirements of the Education 
Department General Administrative Regulations (EDGAR) in Sec.  
75.253(a)(2)(i). This failure could result in loss of funding for year 
two of the project period or termination of the grant;
    (vii) That mandatory random student drug testing will be conducted 
for the entire academic year in the schools selected to implement drug 
testing; and
    (viii) That schools randomly assigned to begin drug testing in year 
one of the grant will not be required to consider students to be in the 
testing pool at any specific point in time unless they are 
participating in a covered activity (for example, all students 
participating at that time in athletics and/or all students 
participating at that time in competitive, extra-curricular, school-
sponsored activities).
    (3) Funds awarded under this program may not be used for any of the 
following purposes:
    (a) Student drug tests administered under suspicion of drug use;
    (b) Incentives for students to participate in the drug-testing 
program;
    (c) Drug treatment;
    (d) Drug prevention curricula or other prevention programs;
    (e) Drug tests for students in non-competitive, extra-curricular 
activities who do not otherwise meet the eligibility criteria;
    (f) Drug tests for students in co-curricular activities who do not 
otherwise meet the eligibility criteria; or
    (g) Drug tests for student drivers who park on campus who do not 
otherwise meet the eligibility criteria.

Selection Criteria

    The Secretary will select from the following criteria those factors 
that will be used to evaluate applications under this competition.
    (1) Need for Project.
    (a) The documented magnitude of student drug use in schools to be 
served by the mandatory random student drug-testing program, including 
the nature, type, and frequency, if known, of drug use by students in 
the target population; and,
    (b) Other evidence, if any, of student drug use in schools to be 
served by the mandatory random student drug-testing program, which may 
include, but is not limited to, reports from parents, students, school 
staff, or law enforcement officials.
    (2) Significance.
    (a) The extent to which the proposed project includes a thorough, 
high-quality review of Federal and State laws and relevant Supreme 
Court decisions related to the proposed student drug-testing program.
    (b) The extent to which the applicant demonstrates school and 
community support for the student drug-testing program and has obtained 
the input of groups representing a diversity of perspectives, for 
example, private schools, parents, counselors, teachers, and school 
board members, in the development of the mandatory random student drug-
testing program; and
    (c) The importance or magnitude of the results or outcomes likely 
to be attained by the mandatory random student drug-testing program in 
the grantee's schools.
    (3) Quality of Project Design.
    (a) The extent to which the project will be based on up-to-date 
knowledge from research and effective practice, including the 
methodology for the random selection of students to be tested and 
procedures outlining the collection, screening, confirmation, and 
review of student drug tests by a certified medical review officer.
    (b) The quality of the applicant's plan to develop and implement a 
mandatory random student drug-testing program that includes--
    (i) Evidence of the applicant's readiness to begin mandatory random 
student drug testing in the first year of the grant; and
    (ii) Detailed procedures outlining how the school will respond to a 
student's positive drug test, including parental notification and 
referral to student assistance programs, drug education, or formal drug 
treatment, if necessary.
    (4) Management Plan.
    (a) The extent to which the applicant describes appropriate chain-
of-custody procedures for test samples and demonstrates a commitment to 
using a federally or nationally accredited lab to process student drug 
tests.
    (b) The quality of the applicant's plan to ensure confidentiality 
of drug test results, including limiting the number of school officials 
who will have access to student drug-testing records.
    (5) Adequacy of resources. The adequacy of support from the 
applicant, including project staff, facilities, equipment, supplies, 
and other resources necessary to implement a high-quality mandatory 
random student drug-testing program.

Executive Order 12866

    This notice of final priority, eligibility and application 
requirements, and selection criteria has been reviewed in accordance 
with Executive Order 12866. Under the terms of the order, we have 
assessed the potential costs and benefits of this regulatory action.
    The potential costs associated with the notice of final priority, 
eligibility and application requirements, and selection criteria are 
those resulting from statutory requirements and those we have 
determined as necessary for administering this program effectively and 
efficiently.
    In assessing the potential costs and benefits--both quantitative 
and qualitative--of this notice of final priority, eligibility and 
application requirements, and selection criteria we have determined 
that the benefits of the final priority and application requirements 
justify the costs. We summarized the costs and benefits in the notice 
of proposed priority, eligibility and application requirements, and 
selection criteria.
    We have also determined that this regulatory action does not unduly 
interfere with State, local, and tribal governments in the exercise of 
their governmental functions.

Intergovernmental Review

    This program is subject to Executive Order 12372 and the 
regulations in 34 CFR part 79. One of the objectives of the Executive 
order is to foster an intergovernmental partnership and a strengthened 
federalism. The Executive order relies on processes developed by State 
and local governments for coordination and review of proposed Federal 
financial assistance.

[[Page 42561]]

    This document provides early notification of our specific plans and 
actions for this program.
    Electronic Access to This Document: You may view this document, as 
well as all other documents of this Department published in the Federal 
Register, in text or Adobe Portable Document Format (PDF) on the 
Internet at the following site: http://www.ed.gov/news/fedregister.
    To use PDF you must have Adobe Acrobat Reader, which is available 
free at this site. If you have questions about using PDF, call the U.S. 
Government Printing Office (GPO), toll free, at 1-888-293-6498; or in 
the Washington, DC, area at (202) 512-1530.

    Note: The official version of this document is the document 
published in the Federal Register. Free Internet access to the 
official edition of the Federal Register and the Code of Federal 
Regulations is available on GPO Access at: http://www.gpoaccess.gov/index.html.


(Catalog of Federal Domestic Assistance Number 84.184D--Grants for 
School Based Student Drug-Testing Programs)

    Program Authority: 20 U.S.C. 7131.

    Dated: July 21, 2006.
Deborah A. Price,
Assistant Deputy Secretary for Safe and Drug-Free Schools.
[FR Doc. 06-6492 Filed 7-25-06; 8:45 am]
BILLING CODE 4000-01-P